Abstract
Objective and background
We present a first description of a Heart Team (HT)-guided approach to coronary revascularization and its long-term effect on clinical events after percutaneous coronary intervention (PCI). The HT approach is a structured process to decide for coronary bypass grafting (CABG), PCI or conservative therapy in ad hoc situations as well as in HT conferences. As a hypothesis, during the long-term course after a PCI performed according to HT rules, a low number of late revascularizations, especially CABGs, are expected (F-PCI study).
Methods
In this monocentric study, the HT approach to an all-comer population was first analyzed and described in general with the help of a database. Next the use of a HT approach was described for a more homogeneous subgroup with newly detected CAD (1.CAD). Those patients in whom the HT decision was PCI (which was a 1.PCI) were then studied with the help of questionnaires for clinical events during a very long-term follow-up. Events were CABG, PCI, diagnostic catheterization (DCath) and death.
Results
A significant number of patients were presented to HT conferences: 22 % out of all 11,174 catheterizations, 24 % out of all 7867 CAD cases and 35 % out of 3408 1.CAD cases. Most of these patients had multi-vessel disease (MVD). Conference decisions were isolated CABG in 46–66 %, PCI in 10–14 %, valvular surgery in 9–16 %, HTx in 10–21 % (Endstage heart failure candidates for surgery) and conservative therapy (Medical or no therapy, additional diagnostic procedures or no adherence to recommended therapy) in 2–3 %. However, most PCIs, ad hoc and elective, were performed under Heart Team rules, but without conference. During follow-up of 1.PCI patients (Kaplan–Meier analysis), CABG occurred in only 15 % of patients, PCI in 37 % and DCath in 65 %; mortality of any course was 51 %. Mortalities were similar in one-vessel disease and in a population of the same year, matched for age and sex (p < 0.057), but mortality was higher in 1.PCI patients with MVD (p < 0.001). Beyond 2 years, Kaplan–Meier curves were linear.
Conclusion
The structured Heart Team approach is an effective tool for ad hoc and conference-based clinical decision-making with a sustained clinical benefit. This is demonstrated in low late CABG (and PCI) rates after a 1.PCI, without elevated mortality. The all-comer population supports the universal value of these data. Stable annual event rates late after PCI suggest a conversion to stable CAD. Heart Team conferences are also important tools in cases of valvular and end-stage heart disease.
Similar content being viewed by others
References
Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961–972
Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D (2010) Guidelines on myocardial revascularization: the Task Force on myocardial revascularisation of the European Society of Cardiology (ESC) an the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31:2501–2555
Harold JG, Bass TA, Bashore TM, Brindis RG, Brush JE, Burke JA, Dehmer GJ, Deychak YA, Jneid H, Jollis JG, Landzberg JS, Levine GN, McClurken JB, Messenger JC, Moussa ID, Muhlestein JB, Pomerantz RM, Sanborn TA, Sivaram CA, White CJ, Williams ES (2013) ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures. J Am Coll Cardiol 62:357–396
Bonzel T, Strupp G, Schreiner G, Kaffee A, Dörge H, Günther HU, Schächinger V (2010) Is coronary artery bypass surgery a frequent event in the longterm course of coronary heart disease after PCI? Poster contribution, Annual Meeting of the European Society of Cardiology. Stockholm
Erbel E, Engel HJ, Kübler W, Meinertz T, Neuhaus KL, Sauer G, Strauer BE, Bonzel T, Ewen K (1997) German guidelines for interventional cardiology (Richtlinien der interventionellen Kardiologie). Z Kardiol 86:1040–1063
McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Boehm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GYH, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 33:1787–1847
Vogt A, Bonzel T, Harmjanz D, von Leitner ER, Pfafferott C, Engel HJ, Niederer W, Schuster PR, Glunz HG, Neuhaus KL, for the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) study group (1997) PTCA registry of German community hospitals. Eur Heart J 18:1110–1114
Mohr D, Bauer J, Höfele F (2003) Business Report Federal Office of Quality Control 2002/2003:80 [Geschäftsbericht Bundesgeschäftsstelle Qualitätssicherung gGmbH (BQS)]. Düsseldorf, p 80
Hamm CW, Albrecht A, Bonzel T, Kelm M, Lange H, Schächinger V, Terres W, Voelker W (2008) Diagnostic catheterisation. Guideline of the German society of cardiology (Diagnostische Herzkatheteruntersuchung). Clin Res Cardiol 97:475–512
Bonzel T, Erbel R, Hamm CW, Levenson B, Neumann FJ, Rupprecht HJ, Zahn R (2008) Guideline of the German society of cardiology for percutaneous coronary interventions (PCI). Clin Res Cardiol 97:513–547
Klein LW (2009) How appropriate for assessing quality are the 2009 appropriateness criteria for coronary revascularisation? J Invasive Cardiol 21:558–562
Farooq V, Serruys PW (2013) Observations from the CREDO-Kyoto three-vessel disease registry: can one adjust for the unadjustable? EuroIntervention 9:419–421
Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S, Esposito R, Ramanathan K, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Barbiere C, Lewis D (2001) Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. J Am Coll Cardiol 38:143–149
King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, Feldman TE, Kern MJ, O’Neill WW, Schaff HV, Whitlow PL, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW (2007) Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. Circulation 117:261–295
Tazaki J, Shiomi H, Morimoto T, Imai M, Yamaji K, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T (2013) Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG registry cohort-2. Eurointervention 9:437–445
Brener S, Haq S, Bose S, Sacchi T (2009) Three-year survival after percutaneous coronary intervention according to appropriateness criteria for revascularisation. J Invasive Cardiol 21:554–557
Daemen J, Kukreja N, Serruys PW (2008) Drug-eluting stents vs. coronary-artery bypass grafting (correspondence). N Engl J Med 358:2641–2644
Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606
Sinning C, Lillpopp L, Appelbaum S, Ojeda F, Zeller T, Schnabel R, Lubos E (2013) Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clin Res Cardiol 102:495–503
Hara H, Aoki J, Tanabe K, Nishi A, Tanimoto S, Nakajima Y, Yahagi K, Nakashima M, Hashimoto T, Asami M, Watanabe M, Yoshida E, Nakajima H, Hara K (2013) Impact of the Clinical Syntax Score on 5-year clinical outcomes after sirolimus-eluting stents implantation. Cardiovasc Interv Ther. doi:10.1007/s12928-013-0165-0(21)
Mohr FM, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR, Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW (2013) Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease, 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381:629–638
Neumann FJ, Cremer J, Falk V, Reifart N, Silber S, Thielmann M (2012) Comments on the joint guidelines on myocardial revascularisation of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) [Kommentar zu den gemeinsamen „Guidelines on myocardial revascularisation“der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS)]. Kardiologe 6:94–104
Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496
Mannebach H (1999) 14. Bericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Z Kardiol 88:234–237
Mannebach H, Hamm C, Horstkotte D (2000) 15. Bericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Z Kardiol 89:55–61
Mannebach H, Hamm CD, Horstkotte D (2000) 16. Bericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Z Kardiol 89:976–984
Mannebach Hamm C, Horstkotte D (2001) 17. Bericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Z Kardiol 90:665–667
Mannebach H, Hamm C, Horstkotte D (2002) 18. Bericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Z Kardiol 91:727–729
Anderson HV, Shaw RE, Brindis RG, Hewitt K, Krone RJ, Block PC, McKay CR, Weintraub WS (2002) A contemporary overview of percutaneous coronary interventions. J Am Coll Cardiol 39:1096–1103
Tognia M, Balmer F, Pfiffner D, Maier W, Zeiher AM, Meier B (2004) on behalf of the Working Group Interventional Cardiology and Coronary Pathophysiology of the European Society of Cardiology. Percutaneous coronary interventions in Europe 1992–2001. Eur Heart J 25:1208–1213
Bruckenberger E (2010) Heart Report (Herzbericht) 2009, Hannover, pp15–123
Bonaros N, Hennerbichler D, Guy F, Kocher A, Pachinger O, Laufer G, Bonatti J (2009) Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 3:846–852
Massoudy P, Thielmann M, Lehmann N, Marr A, Kleikamp G, Malszka A, Zittermann A, Körfer R, Radu M, Krian A, Litmathe J, Gams E, Sezer Ö, Scheld H, Schiller W, Welz A, Dohmen G, Autschbach R, Slottosch I, Wahlers T, Neuhäuser M, Jöckel KH, Jakob H (2009) Impact of prior percutaneous coronay intervention on the outcome of coronary artery bypass surgery: a multicenter analysis. J Thorac Cardiovasc Surg 4:840–845
Hamm CW, Reimers J, Ischinger T, Rupprecht H-J, Berger J, Bleifeld W (1994) For the German Angioplasty Bypass Surgery Investigation: a randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 331:1037–1043
Henderson RA, Pocock SJ, Sharp SJ, Nanchahal K, Sculpher MJ, Buxton MJ, Hampton JR (1998) Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Lancet 352:1419–1425
King SB III, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS (2000) Eight-year mortality in the Emory Angioplasty versus surgery trial (EAST). J Am Coll Cardiol 35:1116–1121
Henderson RA, Pocock SJ, Clayton TC, Knight R, Fox KA, Julian DG, Chamberlain DA (2003) Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 42:1161–1170
The Bari Investigators (2007) The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 49:1600–1606
Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schönberger JP, Buller N, Bonser R, Disco C, Backx B, Hugenholtz PG, Firth BG, Unger F (2005) Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularisation Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46:575–581
Rodriguez AE, Baldi J, Fernández Pereira C, Navia J, Rodriguez Alemparte M, Delacasa A, Vigo F, Vogel D, O’Neill W, Palacios IF (2005) Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 46:582–588
Booth J, Clayton T, Pepper J, Nugara F, Flather M, Sigwart U, Stables RH, on behalf of the SoS investigators (2008) Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the stent or surgery trial (SoS). Circulation 118:381–388
Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha ASC, Hueb AC, Ramires JAF (2010) Ten-year follow-up survival of the medicine, angioplasty, or surgery study (MASS II) A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 122:949–957
Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, Culliford AT, Isom OW, Gold JP, Rose EA (2005) Long-term outcomes of coronary bypass grafting versus stent implantation. N Engl J Med 352:2174–2183
Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC et al (2010) 5-year clinical outcomes of the ARTS II (Arterial Revascularisation Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 55:1093–1101
Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ; Morice MC, Holmnes DR, Feldmasnn TE, Stahle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW (2014) Coronary artery bypass grafting versus percutaneous intervention
Zahn R, Neumann FJ, Büttner HJ, Richardt G, Schneider S, Levenson B, Tebbe U, Sabin G, Nienaber C, Pfannebecker T, Hamm C (2012) Long-term follow-up after coronary stenting with the sirolimus-eluting stent in clinical practice: results from the prospective multi-center German Cypher Stent Registry. Clin Res Cardiol 101:709–716
The VA Coronary Artery Bypass Surgery Cooperative Study Group (1992) Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina. Circulation 86:121–130
Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB (2003) A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: 1–8 year outcomes. J Am Coll Cardiol 41:1293–1304
Trikalinos TA, Aksheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM (2009) Percutaneous coronary interventions for nonacute coronay artery disease: a quantitative twenty-year synopsis and a network meta-analysis. Lancet 373:911–918
Windecker S, Stortecky S, Stefanini GG, daCosta BR, Rutjes AW, Di Nisio M, Siletta MG, Maione A, Alfonso F, Clemmensen PM, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter D, Schauerte P, Sousa Uva M, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, Kolh P, Juni P (2014) Revascularzation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ. doi:10.1136/bmj.g3859
Steg PG, Bhatt DL, Wilson PWF, D’Agostino R, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S, for the REACH Registry Investigators (2007) One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297:1197–1206
Hatrick RI, Ormiston JA, Ruygrok PN, Stewart JT, Webber B, Gonzales H, Webster MW (2009) Very late changes in the dilated lesion following coronary balloon angioplasty: a 17 year serial quantitative angiographic study. EuroIntervention 5:121–126
Acknowledgments
We thank Gerhard Strupp, M.D., Gerhard Schreiner, M.D., Bernd Plappert, M.D. and Michael Conze, M.D., for performing catheterizations, Christine Thomas BBA, Brigitte Kohlman, Sandra Bär and Sabrina Fritsch for technical assistance and Steffen Schneider, Ph.D., IHF GmbH Institut für Herzinfarktforschung, Ludwigshafen, for statistical assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study has been approved by the Ethical Committee of the Hesse State Chamber of Physicians (Landesärztekammer Hessen) and is therefore in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Conflict of interest
All authors declare that they have no potential conflict of interest.
Additional information
For the Fulda F-PCI project.
Rights and permissions
About this article
Cite this article
Bonzel, T., Schächinger, V. & Dörge, H. Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI. Clin Res Cardiol 105, 388–400 (2016). https://doi.org/10.1007/s00392-015-0932-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-015-0932-2